Neuroprotective association of preoperative renin-angiotensin system blocking agents use in patients undergoing carotid interventions.
Chong LiCaron RockmanHeepeel ChangVirendra I PatelJeffrey J SiracuseNeal CayneFrank J VeithJose L TorresThomas S MaldonadoAnjali A NigalayeGlenn JacobowitzKaran GargPublished in: Vascular (2022)
The use of peri-procedural RASB agents was associated with a significantly decreased rate of neurologic events in patients undergoing both CEA and TCAR. This effect was not observed in patients undergoing CAS. As carotid interventions warrant absolute minimization of perioperative complications in order to provide maximum efficacy with regard to stroke protection, the potential neuro-protective effect associated with RASB agents use following CEA and TCAR warrants further examination.